“For too long, we’ve approached glioblastoma treatment knowing that each patient’s tumour contains a complex mixture of cancer cells, but without a clear understanding of how best to target them all,” said Dr. Richard Mair, a brain surgeon and researcher at the Cancer Research UK Cambridge Institute. LiveNOW from FOX reported that an international research team has discovered glioblastoma, one of the most aggressive types of brain cancer, appears to follow a surprisingly organized pattern as it grows, a finding that could lead to better treatments for a disease that is notoriously difficult to remove and often returns after treatment.
The study, published this week in the journal Nature, represents a significant shift in understanding a cancer long viewed as chaotic. By using artificial intelligence and advanced tools to analyze more than 1 million cancer cells from 12 patients treated at Cambridge University Hospitals NHS Foundation Trust, researchers identified a clear progression of three distinct biological stages. This structured evolution suggests that glioblastoma may be more predictable than previously believed, opening new avenues for therapeutic intervention.
A Three-Stage Evolution of a Deadly Tumour
The research reveals that glioblastoma cells move through three main, sequential stages as the tumour grows. In the initial stage, some cancer cells mimic brain stem cells, gathering around the outer edge of the tumour and producing other types of cancer cells. This “stem-like” state is crucial for tumour initiation and growth.
As the tumour expands, the cells adopt a second state, behaving like cells involved in repairing an injury. This mechanism allows the tumour to grow rapidly and creates a distinct layer of cells inside it, facilitating its expansion. In the final stage, the centre of the tumour becomes hypoxic, meaning it receives very little oxygen. Cells in this low-oxygen environment enter a survival mode that makes them significantly more resistant to standard treatments like chemotherapy and radiation therapy.
“This research gives us an opportunity to think differently,” Mair explained. “If we can anticipate the different biological states a tumour is likely to adopt, we can begin to develop treatments that target multiple aspects of the disease from the very beginning.”
Glioblastoma Follows a Predictable Three-Stage Growth Pattern
- Glioblastoma isn’t just a random mix of cells; it follows a predictable three-stage growth pattern, like a blueprint for its attack.
- New treatments could be designed to target the tumour at each specific stage, potentially preventing it from adapting and resisting therapy.
- Focusing on the tumour’s outer edge, where “starter” cells are left behind after surgery, could be key to preventing the cancer from returning.
Genetic Signals Push Cancer Cells Through Stages
The study went beyond identifying the stages; researchers also pinpointed the genetic signals that act as switches, pushing the cancer cells from one stage to the next. This discovery is critical because it suggests that future drugs could potentially block these specific signals, effectively halting the tumour’s progression and making the cancer cells more vulnerable to existing treatments.
The team found that each stage of the cancer's growth is supported by a unique microenvironment within the tumour. The tumour appears to co-opt the body's own immune cells to create these supportive environments.
The team rigorously tested their conclusions using lab-grown mini-brains, known as brain organoids, which allowed them to observe and validate the three-stage pattern in a controlled setting. To make their findings accessible to the global scientific community, the researchers have created the GBM-Space atlas, a free online tool that facilitates the study of glioblastoma on an unprecedented scale.
Implications for Treatment and Regional Healthcare Systems
By understanding the predictable stages of glioblastoma, oncologists could develop combination therapies that simultaneously target cells in different states. For example, a treatment might include one drug to kill the stem-like cells at the tumour’s edge, another to disrupt the repair-like cells in the middle layer, and a third to overcome the hypoxic, treatment-resistant cells at the core. This multi-pronged approach could be more effective than current treatments, which often only target one type of cell.
The study was conducted by an international research team, including members from the Cancer Research UK Cambridge Institute and the Wellcome Sanger Institute.
| Stage of Glioblastoma Growth | Cellular Behavior | Therapeutic Challenge |
|---|---|---|
| 1. Initial | Cells act like brain stem cells, gathering at the tumour’s edge. | Preventing recurrence after surgery by targeting residual edge cells. |
| 3. Core Hypoxia | Cells in low-oxygen center enter a treatment-resistant survival mode. | Overcoming resistance to chemotherapy and radiation. |
The Path Forward: Early Research and Future Studies
While the findings are a major breakthrough, researchers emphasize that the work is still in its preliminary stages. Dr. Omer Bayraktar, co-senior author of the study at the Wellcome Sanger Institute, stated, “Glioblastoma has evaded understanding for years, despite being one of the most studied types of cancer tumour.” The next step is to translate these fundamental biological discoveries into tangible clinical benefits.
“This is early research, but it could help guide the development of treatments that target more of the tumour and keep cancer under control for longer, giving people more time with their loved ones,” said Dr. Marianne Baker, a research information manager at Cancer Research UK. The team’s primary goal now is to conduct further studies to determine whether targeting these newly identified stages and genetic signals can improve patient outcomes in clinical settings.
Seek Medical Evaluation for Brain Tumour Symptoms
This research describes a pattern of disease development and potential future treatment strategies. It is not a current treatment or a diagnostic tool. Individuals experiencing symptoms of a brain tumour, such as persistent headaches, seizures, nausea, vomiting, or changes in personality or vision, should seek immediate medical evaluation. A qualified neurologist or oncologist is the appropriate professional to diagnose and manage glioblastoma. This information is not a substitute for professional medical advice, diagnosis, or treatment.
The study’s publication in Nature signals its importance in the scientific community.
